(Q34627846)

English

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

J P Durand

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

G Deplanque

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

V Montheil

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J M Gornet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

F Scotte

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A Cessot

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

R Coriat

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

E Raymond

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

E Mitry

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

P Herait

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Y Yataghene

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

F Goldwasser

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

22 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

200-205

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21427067%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Exacerbation of oxaliplatin neurosensory toxicity following surgery

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Protection against oxaliplatin acute neurosensory toxicity by venlafaxine

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

The treatment of depression with different formulations of venlafaxine: a comparative analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Invivo antioxidant status: a putative target of antidepressant action

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Regulation of JNK signaling by GSTp

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Pi-class glutathione S-transferase: regulation and function.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR045

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34627846&oldid=1636862549"